Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.49 |
| ▸ | DAO | P14920 | 1/20 | 0.48 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.47 |
| ▸ | KCNA2 | P16389 | 1/20 | 0.46 |
| ▸ | KCNA6 | P17658 | 1/20 | 0.46 |
| ▸ | NT5E | P21589 | 1/20 | 0.46 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.46 |
| ▸ | KCNA4 | P22459 | 1/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.42 |
| ▸ | TOP2A | P11388 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11607646 | 0.92 | MAP2K1 (0.52) | AKR1C3DAOMAP2K1KCNA2KCNA6 | |
| SCHEMBL11605882 | 0.90 | MAP2K1 (0.50) | AKR1C3DAOMAP2K1KCNA2KCNA6 | |
| SCHEMBL11612216 | 0.90 | MAP2K1 (0.50) | AKR1C3DAOMAP2K1KCNA2KCNA6 | |
| SCHEMBL11612130 | 0.88 | MAP2K1 (0.55) | DAOMAP2K1KCNA2KCNA6NT5E | |
| SCHEMBL3422729 | 0.81 | DAO (0.54) | DAOMAP2K1KCNA2KCNA6NT5E | |
| SCHEMBL7152545 | 0.79 | MAP2K1 (0.48) | DAOMAP2K1KCNA2KCNA6NT5E | |
| SCHEMBL13042353 | 0.79 | DAO (0.47) | DAOMAP2K1KCNA2KCNA6NT5E | |
| SCHEMBL1518141 | 0.76 | DAO (0.45) | DAOMAP2K1KCNA2KCNA6NT5E | |
| SCHEMBL11607921 | 0.75 | MAP2K1 (0.62) | KDM4EALDH1A1DAOMAP2K1KCNA2 | |
| SCHEMBL7152718 | 0.75 | DAO (0.43) | DAOMAP2K1KCNA2KCNA6NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6528646-B2 | Pyrrolo(2,3-c)azepin-8-one | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2003-03-04 | — | — | US | disclosed |
| US-20010012891-A1 | Intermediates for the synthesis of debromohymenialdisine and process thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2001-08-09 | — | — | US | disclosed |
| US-6197954-B1 | CATALYTIC REACTION OF METHANESULFONIC ACID IN HYDROGEN BROMIDE; DEBROMINATION OF HYMENIALDISINE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2001-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010012891-A1 | Intermediates for the synthesis of debromohymenialdisine and process thereof | BRSK1, CIAPIN1, BRS3 | KDM4E 2686/4885ALDH1A1 4307/4885AKR1C3 2481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.